Pure Appl. Chem., 2001, Vol. 73, No. 1, pp. 67-75
http://dx.doi.org/10.1351/pac200173010067
Continuing evolution of the drug discovery process in the pharmaceutical industry
CrossRef Cited-by Linking
- Scheffler R. J., Colmer S., Tynan H., Demain A. L., Gullo V. P.: Antimicrobials, drug discovery, and genome mining. Appl Microbiol Biotechnol 2013, 97, 969. <http://dx.doi.org/10.1007/s00253-012-4609-8>
- Katara Pramod: Role of bioinformatics and pharmacogenomics in drug discovery and development process. Netw Model Anal Health Inform Bioinforma 2013, 2, 225. <http://dx.doi.org/10.1007/s13721-013-0039-5>
- Gahtori Prashant, Ghosh Surajit K., Parida Pratap, Prakash Anil, Gogoi Kabita, Bhat Hans Raj, Singh Udaya Pratap: Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Experimental Parasitology 2012, 130, 292. <http://dx.doi.org/10.1016/j.exppara.2011.12.014>
- Trist David G: Scientific process, pharmacology and drug discovery. Curr Opin Pharm 2011, 11, 528. <http://dx.doi.org/10.1016/j.coph.2011.05.008>
- Saxena Vishal, Panicucci Riccardo, Joshi Yatindra, Garad Sudhakar: Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates. J Pharm Sci 2009, 98, 1962. <http://dx.doi.org/10.1002/jps.21592>
- Powers Robert: NMR metabolomics and drug discovery. Magn Reson Chem 2009, 47, S2. <http://dx.doi.org/10.1002/mrc.2461>
- Mittra James: Impact of the life sciences on organisation and management of R&D in large pharmaceutical firms. IJBT 2008, 10, 416. <http://dx.doi.org/10.1504/IJBT.2008.021308>
- Chen Feng, Phoebe Chen Yi-Ping: Identifying targets for drug discovery using bioinformatics. eott 2008, 12, 383. <http://dx.doi.org/10.1517/14728222.12.4.383>
- . D. Pugazhenthi, . S.P. Rajagopalan: Machine Learning Technique Approaches in Drug Discovery, Design and Development . Information Technology J 2007, 6, 718. <http://dx.doi.org/10.3923/itj.2007.718.724>
- Barrett John F, Motyl Mary: What are we looking for in new antibacterials and how do we design it?. Expert Opin Invest Drugs 2006, 15, 85. <http://dx.doi.org/10.1517/13543784.15.2.85>